Bioanalysis | Environmental XPRT
Articles & Whitepapers
-
Hybridization-ELISA in the Bioassay of Oligonucleotide Drugs
Introduction of OligonucleotidesOligonucleotide-based therapeutics represent a rapidly advancing field in current drug development. According to their therapeutic mechanisms, oligonucleotide drugs can be categorized into antisense oligonucleotides (ASOs), small interfering RNA (siRNA), microRNA, anti-gene transcription factor inducers, and nucleic acid aptamers. Oligonucleotide sequences ...
-
Drug-to-Antibody Ratio Analysis Methods
Average drug-to-antibody ratio (DAR) and drug load distribution are two vital properties of antibody drug conjugates (ADCs). Over the years, several ADC bioanalytical methods have been developed to ...
News
-
BOC Sciences: ADC Analysis and Characterization Support Development, Registration, and Release
BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies. The development of antibody-drug conjugates (ADCs) poses challenges to ...
Equipment & Solutions
-
Showcase
ELISA Assay Kits
Most laboratories are familiar with ELISA kits, but developing a kit takes time. Bertin Bioreagent provides ready to use and validated assay kits, for more than 30 years.
